OM:SDOS

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

ScandiDos AB (publ) provides measurement systems and software designed for the QA and validation requirements of the new treatments implemented in clinics worldwide. More Details


Snowflake Analysis

Excellent balance sheet with reasonable growth potential.

Share Price & News

How has ScandiDos's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: SDOS has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-4.1%

SDOS

-7.1%

SE Medical Equipment

-4.2%

SE Market


1 Year Return

-23.9%

SDOS

11.7%

SE Medical Equipment

9.5%

SE Market

Return vs Industry: SDOS underperformed the Swedish Medical Equipment industry which returned 15.7% over the past year.

Return vs Market: SDOS underperformed the Swedish Market which returned 13.4% over the past year.


Shareholder returns

SDOSIndustryMarket
7 Day-4.1%-7.1%-4.2%
30 Day-7.2%-4.7%-0.8%
90 Day-4.1%-0.3%3.6%
1 Year-23.9%-23.9%13.3%11.7%11.5%9.5%
3 Year-69.4%-70.7%59.0%40.7%27.5%13.8%
5 Year-48.6%-53.4%62.3%34.5%54.0%24.2%

Price Volatility Vs. Market

How volatile is ScandiDos's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is ScandiDos undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: SDOS (SEK2.84) is trading below our estimate of fair value (SEK10.11)

Significantly Below Fair Value: SDOS is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: SDOS is unprofitable, so we can't compare its PE Ratio to the SE Medical Equipment industry average.

PE vs Market: SDOS is unprofitable, so we can't compare its PE Ratio to the Swedish market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SDOS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SDOS is good value based on its PB Ratio (2.6x) compared to the SE Medical Equipment industry average (4.5x).


Next Steps

Future Growth

How is ScandiDos forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

99.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SDOS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.5%).

Earnings vs Market: SDOS is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: SDOS's is expected to become profitable in the next 3 years.

Revenue vs Market: SDOS's revenue (14.5% per year) is forecast to grow faster than the Swedish market (3.2% per year).

High Growth Revenue: SDOS's revenue (14.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SDOS's Return on Equity is forecast to be low in 3 years time (17.5%).


Next Steps

Past Performance

How has ScandiDos performed over the past 5 years?

2.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SDOS is currently unprofitable.

Growing Profit Margin: SDOS is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: SDOS is unprofitable, but has reduced losses over the past 5 years at a rate of 2.9% per year.

Accelerating Growth: Unable to compare SDOS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SDOS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.4%).


Return on Equity

High ROE: SDOS has a negative Return on Equity (-23.78%), as it is currently unprofitable.


Next Steps

Financial Health

How is ScandiDos's financial position?


Financial Position Analysis

Short Term Liabilities: SDOS's short term assets (SEK41.0M) exceed its short term liabilities (SEK28.5M).

Long Term Liabilities: SDOS has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: SDOS's debt to equity ratio (3.9%) is considered satisfactory.

Reducing Debt: SDOS's debt to equity ratio has reduced from 6.4% to 3.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SDOS has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if SDOS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is ScandiDos's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate SDOS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SDOS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SDOS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SDOS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SDOS's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.6yrs

Average management tenure


CEO

Gustaf Piehl (42 yo)

0.083

Tenure

Mr. Gustaf Piehl serves as Chief Executive Officer at ScandiDos AB (publ) since September 2020. He Gustaf has many years of experience in the radiation therapy industry after holding a number of different ...


Leadership Team

NamePositionTenureCompensationOwnership
Gorgen Nilsson
Technical Manager0.083yrkr1.99mno data
Ingemar Wiberg
Deputy CEO & Director5.75yrskr1.23mno data
Gustaf Piehl
Chief Executive Officer0.083yrno datano data
Catarina Arkebäck
Chief Financial Officer8.75yrsno datano data
Anders Adolfson
Marketing Manager4yrsno datano data
Peter Reinli
Vice President of Sales1.17yrsno datano data

2.6yrs

Average Tenure

58.5yo

Average Age

Experienced Management: SDOS's management team is considered experienced (2.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ingemar Wiberg
Deputy CEO & Director5.75yrskr1.23mno data
Christer Fåhraeus
Director1.75yrskr50.00kno data
Tom Sundelin
Directorno datakr100.00kno data
Olof Sandén
Chairman of the Board5.75yrskr250.00kno data
Sten Hornsleth
Director1.75yrskr50.00kno data

3.8yrs

Average Tenure

58yo

Average Age

Experienced Board: SDOS's board of directors are considered experienced (3.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

ScandiDos AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: ScandiDos AB (publ)
  • Ticker: SDOS
  • Exchange: OM
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr118.987m
  • Shares outstanding: 41.46m
  • Website: https://scandidos.com

Number of Employees


Location

  • ScandiDos AB (publ)
  • Uppsala Science Park
  • Uppsala
  • 751 83
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SDOSOM (OMX Nordic Exchange Stockholm)YesShare CapitalSESEKApr 2014
2FVDB (Deutsche Boerse AG)YesShare CapitalDEEURApr 2014

Biography

ScandiDos AB (publ) provides measurement systems and software designed for the QA and validation requirements of the new treatments implemented in clinics worldwide. The company offers Delta4 Family soluti ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/26 21:25
End of Day Share Price2020/10/26 00:00
Earnings2020/07/31
Annual Earnings2020/04/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.